FDA Enforcement Tracker
Monitoring regulatory actions, warning letters, and policy changes affecting the peptide market.
NPR covers peptide reclassification (March 26) — mainstream audience discovers peptide market
Read more29 days post-RFK announcement: FDA has STILL not published reclassification — no Federal Register notice, no updated list
Read moreSAFE Drugs Act filed as H.R. 6509 — bipartisan bill would ban RUO sales of compounds identical to FDA-approved drugs
Read morePolitiFact publishes peptide safety fact-check — documents gap between marketing claims and published evidence
Read moreHims & Hers vendor profile added — NYSE-listed telehealth company building peptide manufacturing in California
Read more30+ clinic websites publishing reclassification articles — all financially conflicted, none independent
Read moreBREAKING: Peptide Sciences shuts down operations (March 6) — largest grey-market vendor gone
Read moreFinnrick data: Peptide Sciences BPC-157 scored A, but retatrutide scored E with counterfeit flagged across 37 samples
Read moreMMM Online: 'Get ready for the peptides gold rush' — pharma trade media covers market explosion
Read moreJay Campbell: 'Federal government has decided RUO peptide manufacturing can no longer sell injectable peptides'
Read moreGrips Intelligence: Peptide Sciences was doing $7.4M/month in sales before shutdown — market vacuum now open
Read moreAll American Peptide owners plead guilty — $3M+ forfeitures. Tailor Made Compounding: $1.79M forfeiture.
Read moreSTAT News: 35 of 36 BPC-157 studies are animal-only from single lab with undisclosed conflicts
Read moreAlabama obtains TRO against GLP-1 distributors — first state-level injunctive relief
Read moreFDA issues 50+ warning letters to GLP-1 compounders; DOJ involvement confirmed
Read moreFDA raids Amino Asylum warehouse; website goes offline, operations cease
Read moreFDA declares semaglutide shortage resolved — compounding exception ends
Read moreFDA eliminates Category 2/3 system; prohibited substances remain prohibited
Read moreChinese peptide imports to US double to $328M; online peptide advertising up 678% since 2022
Read morePCAC votes against allowing compounding of ipamorelin, MK-677, CJC-1295, AOD-9604
Read moreFDA moves BPC-157, TB-500, and 15 other peptides to Category 2 — compounding prohibited
Read more